Prothena (PRTA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
BenzingaFeb 24 08:00 ET
Analysts Are Bullish on Top Healthcare Stocks: Prothena (PRTA), Dexcom (DXCM)
TipRanksFeb 23 10:20 ET · Ratings
Prothena Reports 2024 Financial Results and 2025 Outlook
TipRanksFeb 22 22:50 ET
Prothena's Balanced Earnings Call Highlights Growth and Challenges
TipRanksFeb 22 19:05 ET
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus
Zacks Feb 21 13:00 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Prothena Corpto Overweight
BenzingaFeb 21 12:05 ET

Comments

Jaguar8

Dec 19, 2024 10:16

Missed primary endpoint but went up 😂

$Prothena (PRTA.US)$

2

Moomoo AI

Jan 31, 2024 05:38

Investors may miss opportunities or face setbacks if there's no rational basis for the P/S ratio. The moderate P/S ratio suggests investors anticipate a slowdown in revenue. Many investors, less bearish than analysts, hold onto their stocks, risking future disappointment if P/S aligns with growth outlook.

What Prothena Corporation Plc's (NASDAQ:PRTA) P/S Is Not Telling You

Moomoo AI

Nov 28, 2023 05:12

Analysts are forecasting that Prothena will reach break-even point before it might exhaust its cash runway. Given its impressive revenue growth and reduction in cash burn, Prothena appears well positioned to fund further growth with minimal shareholder dilution or borrowing.

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Moomoo AI

Oct 30, 2023 07:14

Despite recent declines, the company's strong growth signals a potential investment opportunity. Market response to its revenue growth indicates interest despite lack of profits.

Prothena (NASDAQ:PRTA) Shareholders Are Still up 224% Over 3 Years Despite Pulling Back 15% in the Past Week

Moomoo AI

Oct 9, 2023 08:34

Overvaluation risk looms for Prothena's shares with high P/S ratio amid poor revenue and weak growth forecast. Investors may face disappointment if the share price realigns with the firm's bleak future outlook.

Prothena Corporation Plc's (NASDAQ:PRTA) Price Is Out Of Tune With Revenues

PRTA Prothena

Trade Overview

Capital Trend

News

Comments

Trending Stocks